You are here: Industry Insights > DPI

News List

Glenmark launches Tiogiva, tiotropium bromide dry powder inhaler in UK expresspharma
June 16, 2021
Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva, in the UK for the treatment of chronic obstructive pulmonary disease (COPD).
Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate contractpharma
April 08, 2021
Kindeva Drug Delivery L.P. and Cambridge Healthcare Innovations Limited (CHI) have entered into a collaboration to develop and commercialize CHI’s αeolus dry-powder inhaler (DPI) platform technology.
Lonza Establishes Center of Excellence in Oregon contractpharma
July 09, 2020
Can now provide capsule-based DPI formulations for feasibility studies in as little as 12 weeks.
Powder Flow: Using Powder Rheology to Develop Generic Dry Powder Inhaler Formulations En-CPhI
October 17, 2019
Dry Powder Inhalers (DPIs) are used to deliver a controlled dose of active pharmaceutical ingredient (API) to the deep lung.
Lonza Launches Capsugel Zephyr DPI Portfolio contractpharma
May 20, 2019
Includes a portfolio of high-quality, customizable DPI capsules of different polymers and compositions, and product customization services.
Hovione Technology announces acquisition of global rights to new pulmonary inhaler device – the Papillon DPI expressbpd
April 16, 2019
Papillon DPI is a single-part, blister-based, reusable inhaler of extreme simplicity, suitable for both chronic and acute treatments...
Hovione Acquires Rights For Inhaler Device contractpharma
April 16, 2019
Affordable, multi-use blister-based dry powder inhaler will be marketed as the Papillon DPI.